Cargando…
δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters
δ-aminolevulinic acid, the precursor of porphyrin biosynthesis has been used to induce the endogenous synthesis of the photosensitiser protoporphyrin IX for photodynamic therapy in the treatment of various tumours. The aim of this work was to characterise the δ-aminolevulinic acid transport system i...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376128/ https://www.ncbi.nlm.nih.gov/pubmed/12177786 http://dx.doi.org/10.1038/sj.bjc.6600481 |
_version_ | 1782154696555757568 |
---|---|
author | Bermúdez Moretti, M Correa García, S Perotti, C Batlle, A Casas, A |
author_facet | Bermúdez Moretti, M Correa García, S Perotti, C Batlle, A Casas, A |
author_sort | Bermúdez Moretti, M |
collection | PubMed |
description | δ-aminolevulinic acid, the precursor of porphyrin biosynthesis has been used to induce the endogenous synthesis of the photosensitiser protoporphyrin IX for photodynamic therapy in the treatment of various tumours. The aim of this work was to characterise the δ-aminolevulinic acid transport system in the murine mammary adenocarcinoma cell line LM3 using (14)C-δ-aminolevulinic acid, to finally improve δ-aminolevulinic acid incorporation in mammalian cells. Our results showed that δ-aminolevulinic acid is incorporated into these cells by two different mechanisms, passive diffusion which is important at the beginning of the incubation, and active transport. Specificity assays suggested that the transporter involved in δ-aminolevulinic acid incorporation is a BETA transporter, probably GAT-2. British Journal of Cancer (2002) 87, 471–474. doi:10.1038/sj.bjc.6600481 www.bjcancer.com © 2002 Cancer Research UK |
format | Text |
id | pubmed-2376128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23761282009-09-10 δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters Bermúdez Moretti, M Correa García, S Perotti, C Batlle, A Casas, A Br J Cancer Experimental Therapeutics δ-aminolevulinic acid, the precursor of porphyrin biosynthesis has been used to induce the endogenous synthesis of the photosensitiser protoporphyrin IX for photodynamic therapy in the treatment of various tumours. The aim of this work was to characterise the δ-aminolevulinic acid transport system in the murine mammary adenocarcinoma cell line LM3 using (14)C-δ-aminolevulinic acid, to finally improve δ-aminolevulinic acid incorporation in mammalian cells. Our results showed that δ-aminolevulinic acid is incorporated into these cells by two different mechanisms, passive diffusion which is important at the beginning of the incubation, and active transport. Specificity assays suggested that the transporter involved in δ-aminolevulinic acid incorporation is a BETA transporter, probably GAT-2. British Journal of Cancer (2002) 87, 471–474. doi:10.1038/sj.bjc.6600481 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-08-12 /pmc/articles/PMC2376128/ /pubmed/12177786 http://dx.doi.org/10.1038/sj.bjc.6600481 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Experimental Therapeutics Bermúdez Moretti, M Correa García, S Perotti, C Batlle, A Casas, A δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title | δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title_full | δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title_fullStr | δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title_full_unstemmed | δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title_short | δ-Aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
title_sort | δ-aminolevulinic acid transport in murine mammary adenocarcinoma cells is mediated by beta transporters |
topic | Experimental Therapeutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376128/ https://www.ncbi.nlm.nih.gov/pubmed/12177786 http://dx.doi.org/10.1038/sj.bjc.6600481 |
work_keys_str_mv | AT bermudezmorettim daminolevulinicacidtransportinmurinemammaryadenocarcinomacellsismediatedbybetatransporters AT correagarcias daminolevulinicacidtransportinmurinemammaryadenocarcinomacellsismediatedbybetatransporters AT perottic daminolevulinicacidtransportinmurinemammaryadenocarcinomacellsismediatedbybetatransporters AT batllea daminolevulinicacidtransportinmurinemammaryadenocarcinomacellsismediatedbybetatransporters AT casasa daminolevulinicacidtransportinmurinemammaryadenocarcinomacellsismediatedbybetatransporters |